Zemplar

Zemplar (paricalcitol) is an oral vitamin D analog prescribed to manage secondary hyperparathyroidism in chronic kidney disease. This overview covers key uses, effects, precautions and interactions for informed decision-making. Always consult a healthcare provider before use.

Paricalcitol is used to reduce elevated parathyroid hormone levels in adults with chronic kidney disease on dialysis. It belongs to a class of medications that help regulate calcium and bone metabolism. People often ask, what is paricalcitol used for, and it is primarily indicated for secondary hyperparathyroidism management.

Paricalcitol helps maintain balanced parathyroid hormone levels to support bone health. Users may notice improved calcium balance over time. Effects vary by individual and ongoing monitoring is recommended.

Keep paricalcitol out of reach of children and store at room temperature away from moisture. Avoid crushing or chewing capsules unless advised by a healthcare professional. Report any unusual symptoms to your doctor promptly.

Paricalcitol may interact with other vitamin D supplements, calcium-based medications or CYP3A inhibitors. Discuss all current medications with your healthcare provider before starting paricalcitol. Alcohol and grapefruit products may also affect how paricalcitol works.